EDGAR Filing Documents for 0001354457-09-000192

Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities:

SEC Accession No. 0001354457-09-000192

Filing Date

2009-07-10

Accepted

2009-07-10 09:52:34

Documents

Confirming Copy

Document Format Files

Seq	Description	Document	Type	Size
1		primary_doc.html	25-NSE
1		primary_doc.xml	25-NSE	1116
2		xtlbdelistreason.txt	EX-99.25	1393
	Complete submission text file	0001354457-09-000192.txt		4444

Mailing Address 711 EXECUTIVE BOULEVARD SUITE Q VALLEY COTTAGE NY 10989

Business Address 711 EXECUTIVE BOULEVARD SUITE Q VALLEY COTTAGE NY 10989 972-8-930-4440

XTL BIOPHARMACEUTICALS LTD (Subject) CIK: 0001023549 (see all company filings)

IRS No.: 000000000
Type: 25-NSE | Act: 34 | File No.: 000-51310
SIC: 2834 Pharmaceutical Preparations

Mailing Address 9600 BLACKWELL RD ROCKVILLE MD 20850

Business Address 9600 BLACKWELL RD ROCKVILLE MD 20850 301-978-4144

NASDAQ Stock Market LLC (Filed by) CIK: 0001354457 (see all company filings)

IRS No.: 521165937 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 25-NSE